Letter: Antipyrine half life and clearance in clinical practice. 1976

B Whitling, and M Ullah, and P A Meredith

UI MeSH Term Description Entries
D008297 Male Males
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone

Related Publications

B Whitling, and M Ullah, and P A Meredith
April 1981, East African medical journal,
B Whitling, and M Ullah, and P A Meredith
January 1987, European journal of clinical pharmacology,
B Whitling, and M Ullah, and P A Meredith
January 1980, Clinical pharmacokinetics,
B Whitling, and M Ullah, and P A Meredith
January 1973, Pharmacology,
B Whitling, and M Ullah, and P A Meredith
November 1977, Clinical pharmacology and therapeutics,
B Whitling, and M Ullah, and P A Meredith
December 1977, Clinical pharmacology and therapeutics,
B Whitling, and M Ullah, and P A Meredith
June 1976, British medical journal,
B Whitling, and M Ullah, and P A Meredith
January 1986, Clinical pharmacokinetics,
B Whitling, and M Ullah, and P A Meredith
December 1970, Scottish medical journal,
B Whitling, and M Ullah, and P A Meredith
October 1984, British journal of clinical pharmacology,
Copied contents to your clipboard!